Primary |
Non-hodgkin's Lymphoma |
22.9% |
Immunosuppression |
15.3% |
Renal Transplant |
7.6% |
Extranodal Nk/t-cell Lymphoma, Nasal Type |
5.3% |
Microscopic Polyangiitis |
4.7% |
Acute Lymphocytic Leukaemia |
4.1% |
Heart Transplant Rejection |
3.5% |
Multiple Sclerosis |
3.5% |
Pneumonia |
3.5% |
Raynaud's Phenomenon |
3.5% |
Scleroderma |
3.5% |
Lichen Sclerosus |
2.9% |
T-cell Lymphoma Stage Iv |
2.9% |
Crohn's Disease |
2.4% |
Graft Versus Host Disease |
2.4% |
Hepatitis Fulminant |
2.4% |
Idiopathic Thrombocytopenic Purpura |
2.4% |
Liver Transplant |
2.4% |
Rheumatoid Arthritis |
2.4% |
Vasculitis |
2.4% |
|
Neutropenia |
11.3% |
Strongyloidiasis |
9.7% |
Respiratory Failure |
8.1% |
Atrial Fibrillation |
6.5% |
Pancreatitis Acute |
6.5% |
Dysmorphism |
4.8% |
Fungal Endocarditis |
4.8% |
Multi-organ Failure |
4.8% |
Neutropenic Sepsis |
4.8% |
Progressive Multifocal Leukoencephalopathy |
4.8% |
Tachycardia |
4.8% |
Bronchopulmonary Aspergillosis |
3.2% |
Cerebral Ischaemia |
3.2% |
Herpes Simplex |
3.2% |
Meningitis Cryptococcal |
3.2% |
Myelopathy |
3.2% |
Myocardial Infarction |
3.2% |
Neonatal Respiratory Distress Syndrome |
3.2% |
Neuromyelitis Optica |
3.2% |
Nocardiosis |
3.2% |
|
Secondary |
Acute Lymphocytic Leukaemia |
14.0% |
Graft Versus Host Disease |
8.0% |
Endocrine Ophthalmopathy |
6.0% |
Glomerulonephritis |
6.0% |
Intestinal T-cell Lymphoma Stage I |
6.0% |
Myxoedema |
6.0% |
Non-hodgkin's Lymphoma |
6.0% |
Scleroderma |
6.0% |
Aspergillosis |
4.0% |
Autoimmune Disorder |
4.0% |
Castleman's Disease |
4.0% |
Hypergammaglobulinaemia |
4.0% |
Microscopic Polyangiitis |
4.0% |
Multiple Sclerosis |
4.0% |
Musculoskeletal Pain |
4.0% |
Pulmonary Alveolar Haemorrhage |
4.0% |
Type 2 Diabetes Mellitus |
4.0% |
Anaemia Haemolytic Autoimmune |
2.0% |
Arthritis |
2.0% |
Eosinophilic Pneumonia |
2.0% |
|
Leukocytosis |
13.0% |
White Blood Cell Count Increased |
13.0% |
Bronchopulmonary Aspergillosis |
8.7% |
Hyperglycaemia |
4.3% |
Intra-abdominal Haemorrhage |
4.3% |
Lymphopenia |
4.3% |
Multi-organ Failure |
4.3% |
Muscular Dystrophy |
4.3% |
Muscular Weakness |
4.3% |
Neutropenic Sepsis |
4.3% |
Pneumatosis Intestinalis |
4.3% |
Post Transplant Distal Limb Syndrome |
4.3% |
Pulmonary Tuberculosis |
4.3% |
Respiratory Tract Infection |
4.3% |
Reversible Posterior Leukoencephalopathy Syndrome |
4.3% |
Tuberculosis |
4.3% |
Ventricular Fibrillation |
4.3% |
Weight Decreased |
4.3% |
|
Interacting |
Acne |
33.3% |
Headache |
33.3% |
Hypersensitivity |
33.3% |
|
|